advanced search  
Updated Jul. 1, 2009
 
 
 
WEB EXCLUSIVE
• Jackson Death Renews Debate Over Propofol Status
Hospital sedative found in singer's home
POSTED: 7/1/2009
• HOPA Coverage: Should All HR+ Breast Cancer Patients Planning Treatment With Tamoxifen Be Tested for CYP2D6?
POSTED: 6/22/2009
• HOPA Coverage: Should Genetic Testing for VKORC1 Be Done in All Patients Receiving Warfarin?
POSTED: 6/22/2009
• HOPA Coverage: Nonadherent Patients Cost the Health Care System Big Bucks
POSTED: 6/19/2009
• ASHP Coverage: Sweating Out the Causes of BCMA Breakdowns
Quality improvement ‘workout teams’ nearly eliminate nurse overrides, boost patient safety
POSTED: 6/19/2009
• ASHP Coverage: Remote Camera To Check Chemotherapy Orders Saves Time and Money
POSTED: 6/19/2009
NOAH Supports Neoadjuvant Herceptin, but Timing Elusive
 ISSUE: JUNE, 2009
San Antonio—Adding trastuzumab (Herceptin, Genentech) to neoadjuvant chemotherapy extends event-free survival (EFS) in women with locally advanced HER2-positive breast cancer, according to final results of the Phase III NOAH (NeOAdjuvant Herceptin) trial. read more
New Cold Storage Strategies Help Protect High-Cost Drugs
 ISSUE: JUNE, 2009
New methods of storing high-cost biologics and medications that require refrigeration can help ensure the integrity and accurate dispensing of these products. read more
IVIG and Aseptic Meningitis
 ISSUE: JUNE, 2009
Jerry Siegel, PharmD, FASHP discusses this rare but serious side effect of immune globulin therapy. read more
Load Up With a Statin Before Elective PCI
 Study shows strategy can protect the heart.
ISSUE: JUNE, 2009
Orlando, Fla.—Giving patients one or two loading doses of atorvastatin on the day before elective percutaneous coronary intervention (PCI) has a cardioprotective effect, whether or not the patients were receiving maintenance statin therapy, according to two studies from Italy presented at the American College of Cardiology 2009 annual meeting. read more
Development of Guidance for Establishing Bioequivalence for Nonabsorbed Antibiotics: A Pathway Fraught With Challenges

Non-Absorbed Locally Acting drugs: Implications of Imminent Guidances Office of Generic Drugs recently issued draft guidance on methods to establish bioequivalence of generic and branded agents such as oral non-absorbed antibiotics. If equivalence is not proven then the implications to patient and society for certain antibiotics are significant.

To request a free hard copy of this Bench to Bedside article, please email your full name, mailing address, and institution to pharmacypracticenews@mcmahonmed.com
 


 
• New Compendia Study Says Off-Label Resources Are Outdated, Flawed 1
• Waking Up to the Benefits Of Less Sedatives in the ICU 1
• Guide to Cancer Therapeutic Regimens 2008 1
CLINICAL
• IVIG and Aseptic Meningitis...  [6/2009]
• Oncology Supportive Care Poses Challenges, Opportu...  [6/2009]
• Load Up With a Statin Before Elective PCI...  [6/2009]
more 
OPERATIONS & MANAGEMENT
• FFF Enterprises Responds to Flu Crises...  [6/2009]
• Life Portfolio: Under Construction...  [6/2009]
• Economic Picture Featured Heavily In ASHP Summer M...  [6/2009]
more 
POLICY
• The Impact of the Economy On Pharmacy Services ...  [6/2009]
• FDA Amends Opioid Ban...  [6/2009]
• Prospective Review of Drug Orders Called Into Ques...  [5/2009]
more 
TECHNOLOGY
• High-Tech Enhancements on Tap in Outpatient Pharma...  [6/2009]
• Stimulating More Widespread EHR Adoption...  [6/2009]
• New Cold Storage Strategies Help Protect High-Cost...  [6/2009]
more 

JUNE, 2009
FREE PRINT SUBSCRIPTION
 
 
 
home  |  about us  |  advertise  |  contact  |  publications
 


Copyright © 2004 - 2009 McMahon Publishing unless otherwise noted.
All rights reserved. Reproduction in whole or in part without permission is prohibited.